View:
Mini BasicThis view is available after user registration.
 ShortThis view is available when you buy a license.
 StandardThis view is available when you buy a license.
 CompleteThis view is available when you buy a license.
 BV-ICE - Brentuximab Vedotin 1.8 / Etoposide 100 / Carboplatin 5 / Ifosfamide 5, T-cell Lymphoma
Protocol-ID: 2420 V1.0 (Mini), BV-ICE (BRNT1.8/ETOP100/CRBP5/IFOS5), T-NHLIndication(s)
- NHL, T-cell type; ICD-10 C84.5
 CD30+
- NHL, T-Cell Type, Adult T-Cell Leukemia or Lymphoma; ICD-10 C91.5-
 CD30+
- NHL, T-Cell Type, Anaplastic Large Cell; ICD-10 C84.4
 CD30+
- NHL, T-Cell Type, Anaplastic Large Cell Lymphoma, ALK negative; ICD-10 C84.7
 CD30+
- NHL, T-Cell Type, Anaplastic Large Cell Lymphoma, ALK-positive; ICD-10 C84.6
 CD30+
- NHL, T-Cell Type, Angioimmunoblastic; ICD-10 C86.5
 CD30+
- NHL, T-Cell Type, Enteropathy Type; ICD-10 C86.2
 CD30+
- NHL, T-Cell Type, Hepatosplenic; ICD-10 C86.1
 CD30+
- NHL, T-Cell Type, Peripheral, Unspecified; ICD-10 C84.4
 CD30+
| The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. | 
Valid since: 30.08.2023
 
					